Cartesian Therapeutics, Inc. (RNAC) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 78K | 947K | 452K | 298K | 1.1M | -759K | 387K | 33.45M | 5.84M | 8.27M | 6.55M | 5.25M |
| Revenue Growth % | -92.91% | 224.77% | 16.8% | -99.11% | -81.16% | -109.18% | -94.09% | 537.17% | -1.65% | -50.78% | -68.37% | -86.63% |
| Cost of Goods Sold | 0 | 0 | 12.8M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 13M | 17.78M |
| COGS % of Revenue | - | - | 2831.19% | - | - | - | - | - | - | - | 198.47% | 338.77% |
| Gross Profit | 78K | 947K | -12.35M | 298K | 1.1M | -759K | 387K | 33.45M | 5.84M | 8.27M | -6.45M | -12.53M |
| Gross Margin % | 100% | 100% | -2731.19% | 100% | 100% | 100% | 100% | 100% | 100% | 100% | -98.47% | -238.77% |
| Gross Profit Growth % | -92.91% | 224.77% | -3289.92% | -99.11% | -81.16% | -109.18% | 106% | 366.86% | 146.03% | -48.94% | -131.98% | -132.32% |
| Operating Expenses | 26.58M | 22.89M | 8.72M | 22.11M | 22.99M | 25.97M | 17.96M | 19.69M | 19.19M | 44.6M | 6.61M | 6.11M |
| OpEx % of Revenue | 34073.08% | 2416.68% | 1929.42% | 7419.13% | 2089.91% | -3421.87% | 4641.34% | 58.87% | 328.56% | 539.54% | 100.96% | 116.31% |
| Selling, General & Admin | 7.11M | 8.2M | 7.72M | 7.24M | 8.31M | 7.09M | 6.56M | 7.03M | 9.45M | 22.17M | 6.61M | 6.11M |
| SG&A % of Revenue | 9120.51% | 865.58% | 1707.08% | 2429.53% | 755.91% | -933.73% | 1695.61% | 21.01% | 161.82% | 268.17% | 100.96% | 116.31% |
| Research & Development | 19.46M | 14.69M | 13.8M | 14.87M | 14.67M | 11.31M | 11.4M | 12.66M | 9.74M | 22.43M | 13M | 17.78M |
| R&D % of Revenue | 24952.56% | 1551.11% | 3053.54% | 4989.6% | 1334% | -1489.59% | 2945.74% | 37.86% | 166.75% | 271.36% | 198.47% | 338.77% |
| Other Operating Expenses | 0 | 0 | -1000K | 0 | 0 | 1000K | 0 | 0 | 0 | 0 | -1000K | -1000K |
| Operating Income | -26.5M | -21.94M | -21.07M | -21.81M | -21.89M | -26.73M | -17.57M | 13.76M | -13.35M | -36.33M | -13.06M | -18.64M |
| Operating Margin % | -33973.08% | -2316.68% | -4660.62% | -7319.13% | -1989.91% | 3521.87% | -4541.34% | 41.13% | -228.56% | -439.54% | -199.44% | -355.08% |
| Operating Income Growth % | -21.06% | 17.93% | -19.86% | -258.54% | -63.99% | 26.43% | -34.52% | 173.81% | 27.38% | -327.64% | -717.07% | -234.47% |
| EBITDA | -26.5M | -21.94M | -20.46M | -21.22M | -20.73M | -26.25M | -17.29M | 13.95M | -13.16M | -36.06M | -12.88M | -18.46M |
| EBITDA Margin % | -33973.08% | -2316.68% | -4526.55% | -7121.48% | -1884.82% | 3457.84% | -4467.44% | 41.72% | -225.43% | -436.24% | -196.55% | -351.72% |
| EBITDA Growth % | -27.81% | 16.41% | -18.34% | -252.1% | -57.49% | 27.22% | -34.27% | 175.58% | 27.57% | -357.09% | -1114.72% | -228.58% |
| D&A (Non-Cash Add-back) | 0 | 0 | 606K | 589K | 1.16M | 486K | 286K | 196K | 183K | 272K | 189K | 176K |
| EBIT | -26.5M | -21.94M | -35.9M | 15.89M | -21.89M | -9.97M | -24.18M | 13.76M | -13.35M | -196.66M | -13.06M | -18.64M |
| Net Interest Income | 1.03M | 1.27M | 1.55M | 1.75M | 2.02M | 7.39M | 2.57M | 1.2M | 1.16M | 940K | -1.27M | -752K |
| Interest Income | 1.03M | 1.27M | 1.55M | 1.75M | 2.02M | 7.39M | 2.57M | 1.2M | 1.16M | 940K | 0 | 0 |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.27M | 752K |
| Other Income/Expense | -12.68M | -79.83M | -14.84M | 37.7M | 4.18M | 16.77M | -6.61M | 79K | -43.48M | -160.33M | 4.06M | 7.25M |
| Pretax Income | -39.18M | -101.77M | -35.9M | 15.89M | -17.71M | -9.97M | -24.18M | 13.84M | -56.82M | -196.66M | -9M | -11.39M |
| Pretax Margin % | -50233.33% | -10746.46% | -7942.92% | 5330.87% | -1610% | 1313.04% | -6248.84% | 41.37% | -973.01% | -2379.12% | -137.41% | -216.94% |
| Income Tax | 0 | -9.19M | 0 | 0 | 0 | 287K | 0 | 0 | 0 | -19M | 0 | 0 |
| Effective Tax Rate % | 0% | 9.03% | 0% | 0% | 0% | -2.88% | 0% | 0% | 0% | 9.66% | 0% | 0% |
| Net Income | -39.18M | -92.58M | -35.9M | 15.89M | -17.71M | -10.25M | -24.18M | 13.84M | -56.82M | -177.66M | -9M | -11.39M |
| Net Margin % | -50233.33% | -9775.71% | -7942.92% | 5330.87% | -1610% | 1350.86% | -6248.84% | 41.37% | -973.01% | -2149.26% | -137.41% | -216.94% |
| Net Income Growth % | -121.24% | -802.92% | -48.46% | 14.82% | 68.83% | 94.23% | -168.64% | 221.51% | -162.31% | -3114.73% | -14.05% | -232.39% |
| Net Income (Continuing) | -39.18M | -92.58M | -35.9M | 15.89M | -17.71M | -10.25M | -24.18M | 13.84M | -56.82M | -177.66M | -9M | -11.39M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -1.46 | -3.46 | -1.38 | 0.60 | -0.68 | -0.07 | -1.13 | 0.54 | -10.50 | -41.56 | -1.74 | -2.23 |
| EPS Growth % | -114.71% | -4914.49% | -22.12% | 11.11% | 93.52% | 99.83% | 35.06% | 124.22% | -147.64% | -3682.76% | -12.26% | -228.16% |
| EPS (Basic) | -1.46 | -3.56 | -1.38 | 0.61 | -0.68 | -0.07 | -1.13 | 0.58 | -10.50 | -41.56 | -1.74 | -2.23 |
| Diluted Shares Outstanding | 26.86M | 25.97M | 26M | 26.45M | 25.9M | 25.91M | 21.47M | 17.79M | 5.41M | 5.17M | 5.16M | 5.11M |
| Basic Shares Outstanding | 26.86M | 25.97M | 26M | 25.98M | 25.9M | 25.91M | 21.47M | 16.72M | 5.41M | 5.17M | 5.16M | 5.11M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |